An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT03896295. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
Study identification
- NCT ID
- NCT03896295
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Momenta Pharmaceuticals, Inc.
- Industry
- Enrollment
- 37 participants
Conditions and interventions
Conditions
Interventions
- M281 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 5, 2019
- Primary completion
- Dec 8, 2020
- Completion
- Dec 8, 2020
- Last update posted
- Jun 26, 2023
2019 – 2020
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Momenta Investigational Site | Phoenix | Arizona | 85013 | — |
| Momenta Investigational Site | Los Angeles | California | 90048 | — |
| Momenta Investigational Site | Orange | California | 92868 | — |
| Momenta Investigational Site | Stanford | California | 94305 | — |
| Momenta Investigational Site | Aurora | Colorado | 80045 | — |
| Momenta Investigational Site | New Haven | Connecticut | 06511 | — |
| Momenta Investigational Site | Boca Raton | Florida | 33487 | — |
| Momenta Investigational Site | Maitland | Florida | 32751 | — |
| Momenta Investigational Site | Port Charlotte | Florida | 33952 | — |
| Momenta Investigational Site | St. Petersburg | Florida | 33713 | — |
| Momenta Investigational Site | Augusta | Georgia | 30912 | — |
| Momenta Investigational Site | Fairway | Kansas | 66205 | — |
| Momenta Investigational Site | Boston | Massachusetts | 02114 | — |
| Momenta Investigational Site | Boston | Massachusetts | 02115 | — |
| Momenta Investigational Site | Boston | Massachusetts | 02215 | — |
| Momenta Investigational Site | New Brunswick | New Jersey | 08550 | — |
| Momenta Investigational Site | New York | New York | 10021 | — |
| Momenta Investigational Site | Charlotte | North Carolina | 28207 | — |
| Momenta Investigational Site | Durham | North Carolina | 27710 | — |
| Momenta Investigational Site | Raleigh | North Carolina | 27607 | — |
| Momenta Investigational Site | Cincinnati | Ohio | 45267 | — |
| Momenta Investigational Site | Columbus | Ohio | 43210 | — |
| Momenta Investigational Site | Cordova | Tennessee | 38106 | — |
| Momenta Investigational Site | Austin | Texas | 78756 | — |
| Momenta Investigational Site | Round Rock | Texas | 78681 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03896295, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2023 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03896295 live on ClinicalTrials.gov.